pyrimethamine has been researched along with Acquired Immune Deficiency Syndrome in 105 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine (1500 mg 4 times daily) as treatment for acute disease (for 6 weeks) and as maintenance therapy (for 42 weeks) for toxoplasmic encephalitis (TE) in patients infected with human immunodeficiency virus." | 9.10 | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche ( Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL, 2002) |
| "Sixty-five patients intolerant of conventional toxoplasmic encephalitis therapies-pyrimethamine, sulphadiazine or clindamycin-received atovaquone as maintenance therapy after resolution of an acute episode of toxoplasmic encephalitis." | 9.08 | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. ( Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F, 1996) |
| "The interim results are presented of an ongoing large-scale, prospective, randomized study to determine the potential role of clindamycin in the treatment of toxoplasmic encephalitis." | 9.07 | Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Dannemann, BR; Israelski, DM; Leport, C; Luft, BJ; McCutchan, JA; Nussbaum, JN; Orellana, M; Vildé, JL, 1991) |
| "A double-blind, placebo-controlled trial was set up to compare clindamycin and pyrimethamine as prophylaxis for toxoplasmic encephalitis (TE) in HIV-infected patients at risk of the disorder." | 9.07 | Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDS. ( Besch, CL; Child, C; Deyton, L; Hafner, R; Jacobson, MA; Matts, JP; Muth, K; Wentworth, DN, 1992) |
| "To compare pyrimethamine plus clindamycin (PC) to pyrimethamine plus sulfadiazine (PS) as a treatment for toxoplasmic encephalitis (TE) in patients with the acquired immunodeficiency syndrome (AIDS)." | 9.07 | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Clumeck, N; Dannemann, B; Israelski, D; Leport, C; Luft, B; McCutchan, JA; Morlat, P; Nussbaum, J, 1992) |
| "Cerebral toxoplasmosis related to AIDS was treated with a combination regimen of pyrimethamine, clindamycin, and spiramycin, and in a second trial with a combination of pyrimethamine and clindamycin." | 7.68 | Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system. ( Pohle, HD; Ruf, B, 1991) |
| "Fourteen patients with AIDS and toxoplasmic encephalitis, who could not be treated with the standard regimen of pyrimethamine and a sulfonamide due to a previous history of bone marrow suppression and severe allergic reactions to sulfonamides, were treated with oral clindamycin and pyrimethamine." | 7.68 | A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. ( Bini, T; Esposito, R; Foppa, CU; Gregis, G; Lazzarin, A; Moroni, M, 1991) |
| "The combination of pyrimethamine and clindamycin, both administered orally, was evaluated for initial and maintenance therapy of toxoplasmosis in eight AIDS patients who were either allergic to sulfonamides or unresponsive to standard therapy." | 7.68 | Treatment of acute toxoplasmosis with oral clindamycin. ( Rolston, KV, 1991) |
| "Thirty-five patients with the acquired immunodeficiency syndrome (AIDS) and central nervous system toxoplasmosis, seen over a 30-month period, were treated with the combination pyrimethamine/sulfadiazine." | 7.67 | Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. ( Katlama, C; Leport, C; Marche, C; Matheron, S; Raffi, F; Regnier, B; Saimot, AG; Vedrenne, C; Vilde, JL, 1988) |
| "Three patients with acquired immune deficiency syndrome (AIDS), central nervous system toxoplasmosis, and hypersensitivity to sulfadiazine were given treatment with clindamycin plus pyrimethamine." | 7.67 | Role of clindamycin in the treatment of central nervous system toxoplasmosis. ( Hoy, J; Rolston, KV, 1987) |
| "Toxoplasma gondii encephalitis is an important opportunistic infection in the acquired immunodeficiency syndrome, estimated to occur in 20,000 to 40,000 patients with acquired immunodeficiency syndrome in the United States by 1991." | 6.38 | Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. ( Brosius, FC; Rothstein, DM; Simon, DI, 1990) |
| "In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine (1500 mg 4 times daily) as treatment for acute disease (for 6 weeks) and as maintenance therapy (for 42 weeks) for toxoplasmic encephalitis (TE) in patients infected with human immunodeficiency virus." | 5.10 | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche ( Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL, 2002) |
| "Sixty-five patients intolerant of conventional toxoplasmic encephalitis therapies-pyrimethamine, sulphadiazine or clindamycin-received atovaquone as maintenance therapy after resolution of an acute episode of toxoplasmic encephalitis." | 5.08 | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. ( Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F, 1996) |
| "The interim results are presented of an ongoing large-scale, prospective, randomized study to determine the potential role of clindamycin in the treatment of toxoplasmic encephalitis." | 5.07 | Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Dannemann, BR; Israelski, DM; Leport, C; Luft, BJ; McCutchan, JA; Nussbaum, JN; Orellana, M; Vildé, JL, 1991) |
| "A double-blind, placebo-controlled trial was set up to compare clindamycin and pyrimethamine as prophylaxis for toxoplasmic encephalitis (TE) in HIV-infected patients at risk of the disorder." | 5.07 | Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDS. ( Besch, CL; Child, C; Deyton, L; Hafner, R; Jacobson, MA; Matts, JP; Muth, K; Wentworth, DN, 1992) |
| "We retrospectively examined 39 patients with AIDS and central nervous system toxoplasmosis in order to determine the efficacy and safety of two combinations: pyrimethamine-sulfadiazine and pyrimethamine-clindamycin." | 5.07 | Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS. ( Ammassari, A; Antinori, A; Camilli, G; Damiano, F; Federico, G; Maiuro, G; Pizzigallo, E; Tamburrini, E, 1992) |
| "To compare pyrimethamine plus clindamycin (PC) to pyrimethamine plus sulfadiazine (PS) as a treatment for toxoplasmic encephalitis (TE) in patients with the acquired immunodeficiency syndrome (AIDS)." | 5.07 | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Clumeck, N; Dannemann, B; Israelski, D; Leport, C; Luft, B; McCutchan, JA; Morlat, P; Nussbaum, J, 1992) |
| "The widespread emergence of chloroquine-resistant Plasmodium falciparum led to the formulation of an effective, fixed combination of two antimalarial agents, pyrimethamine and the long-acting sulfonamide sulfadoxine, for prophylaxis and treatment." | 4.77 | Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. ( Hewlett, EL; Pearson, RD, 1987) |
| "In 26 AIDS patients treated for toxoplasmic encephalitis, the inhibitory effect on Toxoxplasma growth of sequential sera taken before and after initiation of therapy was determined using a culture-based immunoassay and compared with pyrimethamine blood levels." | 3.70 | Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis. ( Derouin, F; Farinotti, R; Gérard, L; Leport, C; Maslo, C, 1998) |
| "A proportion of patients with AIDS and toxoplasmic encephalitis (TE) sustain low plasma pyrimethamine concentrations during oral treatment, possibly because of incomplete and variable bioavailability." | 3.70 | Disposition of intravenous pyrimethamine in healthy volunteers. ( Almond, DS; Edwards, G; Lee, MG; Szwandt, IS; Winstanley, PA, 2000) |
| "The combination of pyrimethamine and clindamycin, both administered orally, was evaluated for initial and maintenance therapy of toxoplasmosis in eight AIDS patients who were either allergic to sulfonamides or unresponsive to standard therapy." | 3.68 | Treatment of acute toxoplasmosis with oral clindamycin. ( Rolston, KV, 1991) |
| "Fourteen patients with AIDS and toxoplasmic encephalitis, who could not be treated with the standard regimen of pyrimethamine and a sulfonamide due to a previous history of bone marrow suppression and severe allergic reactions to sulfonamides, were treated with oral clindamycin and pyrimethamine." | 3.68 | A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. ( Bini, T; Esposito, R; Foppa, CU; Gregis, G; Lazzarin, A; Moroni, M, 1991) |
| "Cerebral toxoplasmosis related to AIDS was treated with a combination regimen of pyrimethamine, clindamycin, and spiramycin, and in a second trial with a combination of pyrimethamine and clindamycin." | 3.68 | Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system. ( Pohle, HD; Ruf, B, 1991) |
| "Thirty-five patients with the acquired immunodeficiency syndrome (AIDS) and central nervous system toxoplasmosis, seen over a 30-month period, were treated with the combination pyrimethamine/sulfadiazine." | 3.67 | Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. ( Katlama, C; Leport, C; Marche, C; Matheron, S; Raffi, F; Regnier, B; Saimot, AG; Vedrenne, C; Vilde, JL, 1988) |
| "The combination of pyrimethamine and sulfadoxine (Fansidar) has been reported to cause severe skin reactions including erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis." | 3.67 | Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person. ( Dinan, WA; Pablos-Mendez, A; Palagiano, A; Raviglione, MC; Sabatini, MT, 1988) |
| "Three patients with acquired immune deficiency syndrome (AIDS), central nervous system toxoplasmosis, and hypersensitivity to sulfadiazine were given treatment with clindamycin plus pyrimethamine." | 3.67 | Role of clindamycin in the treatment of central nervous system toxoplasmosis. ( Hoy, J; Rolston, KV, 1987) |
| "Cerebral toxoplasmosis is the most frequent opportunistic infection in patients with acquired immune deficiency syndrome in France." | 2.67 | [Primary prophylaxis against cerebral toxoplasmosis. Efficacy of folinic acid in the prevention of hematologic toxicity of pyrimethamine]. ( Barbeau, P; Brossard, G; Leng, B; Neau, D; Pellegrin, JL, 1994) |
| "Toxoplasmic encephalitis in AIDS patients was usually treated with sulfonamides combined with other drugs and the pooled CR was 49." | 2.52 | A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans. ( Lindsay, DS; Peng, HJ; Wei, HX; Wei, SS, 2015) |
| "Toxoplasma gondii encephalitis is an important opportunistic infection in the acquired immunodeficiency syndrome, estimated to occur in 20,000 to 40,000 patients with acquired immunodeficiency syndrome in the United States by 1991." | 2.38 | Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. ( Brosius, FC; Rothstein, DM; Simon, DI, 1990) |
| "In patients with AIDS, toxoplasmosis is the most common cause of CNS mass lesions." | 2.38 | Toxoplasmosis in AIDS patients. ( Tuazon, CU, 1989) |
| " Dosage must be adjusted to the results of blood counts." | 2.38 | [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients]. ( Leport, C; Niyongabo, T; Vildé, JL, 1991) |
| "The literature on toxoplasmosis in the acquired immune deficiency syndrome is reviewed with reference to more than 140 cases from various centres." | 2.37 | Toxoplasmosis and the acquired immune deficiency syndrome. ( Holliman, RE, 1988) |
| "We describe the course of 36 AIDS patients with cerebral toxoplasmosis and present a review of clinical signs, diagnosis, therapy, and survival times." | 1.31 | [HIV-associated cerebral toxoplasmosis -- review and retrospective analysis of 36 patients]. ( Evers, S; Fischer, A; Freund, M; Grüneberg, U; Happe, S; Heese, Ch; Husstedt, IW; Kloska, S; Reichelt, D, 2002) |
| "To analyse the incidence of Pneumocystis carinii pneumonia after the withdrawal of prophylaxis, in patients with AIDS who were receiving HAART (highly active antiretroviral treatment)." | 1.30 | [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases]. ( de Górgolas Hernández, M; Fernández Guerrero, ML; García Delgado, R; García Vázquez, E, 1999) |
| "ET was the AIDS-defining condition in 44% of the patients." | 1.29 | [Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients]. ( Barrio, JL; Cadafalch, J; Domingo, P; Ferrer, S; Fuentes, I; Fuster, M; Iranzo, A; Muñoz, C; Nolla, J; Ris, J; Sambeat, MA, 1996) |
| "The anticryptosporidial activity of four macrolides alone and in combination with other antimicrobial agents was investigated against ten clinical isolates of Cryptosporidium parvum recovered from stools of AIDS patients." | 1.29 | In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. ( Cirioni, O; Giacometti, A; Scalise, G, 1996) |
| "Nineteen cases of cerebral toxoplasmosis (CTOX) are reported from a group of Edinburgh AIDS patients." | 1.29 | Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. ( Brettle, RP; Burns, SM; Flegg, PJ; Laing, RB; Leen, CL, 1996) |
| "In particular, in patients with AIDS who are more susceptible for adverse drug reactions and who are simultaneously receiving a variety of drugs with a considerable potential of cutaneous side effects, therapy cannot be withhold for lack of therapeutic alternatives." | 1.29 | [Drug-induced Stevens-Johnson syndrome in a patient with AIDS]. ( Bircher, A; Haefeli, WE; Leib, SL; Lüscher, TF; Schlienger, RG, 1993) |
| "Pneumocystis carinii pneumonia has been the most common life-threatening opportunistic infection in patients with acquired immunodeficiency syndrome." | 1.29 | Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia. ( Glatt, AE, 1994) |
| "gondii cysts in their brains." | 1.28 | Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. ( Araujo, FG; Lin, T; Prokocimer, P; Remington, JS, 1992) |
| "No relapse was observed in those receiving P/S, but 40% of those treated with P/C relapsed." | 1.28 | [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]. ( Alvarez, R; Gatell, JM; González-Clemente, JM; Graus, F; Guelar, A; Jiménez de Anta, MT; Mallolas, J; Mercader, JM; Miró, JM; Pedrol, E, 1990) |
| "Pulmonary toxoplasmosis in AIDS is rare." | 1.28 | [Pulmonary toxoplasmosis in AIDS. Report of 3 cases]. ( Bouslama, K; Cabane, J; Gonzalez Canali, G; Imbert, JC; Knani, L; Lebas, J; Varette, C, 1990) |
| "Eight episodes were proven Pneumocystis carinii pneumonia, 18 satisfied Centres for Disease Control criteria for presumptive Pneumocystis carinii pneumonia and 11 lacked one Centres for Disease Control criterion." | 1.28 | Experience with pneumocystis carinii pneumonia in patients with AIDS. ( Davis, R; Ellis-Pegler, RB; Ingram, RJ, 1989) |
| "Patients with cerebral toxoplasmosis have a low risk for subsequently developing P." | 1.28 | Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. ( Chave, JP; Flepp, M; Gabriel, V; Heald, A; Hirschel, B; Malinverni, R; Renold, C; Rüttimann, S; Sugar, A, 1991) |
| "In 33 consecutive AIDS patients with a first episode of Pneumocystis carinii pneumonia (PCP) we evaluated treatment, outcome, recurrence rate and pyrimethamine as chemoprophylaxis in a 1-year follow-up." | 1.28 | Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis. ( Bergdahl, S; Julander, I; Lidman, C; Lundbergh, P; Ortqvist, A, 1989) |
| "Toxoplasma encephalitis has been reported as a life-threatening opportunistic infection among patients with the acquired immune deficiency syndrome." | 1.27 | Assessment of therapy for toxoplasma encephalitis. The TE Study Group. ( Haverkos, HW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (35.24) | 18.7374 |
| 1990's | 59 (56.19) | 18.2507 |
| 2000's | 6 (5.71) | 29.6817 |
| 2010's | 2 (1.90) | 24.3611 |
| 2020's | 1 (0.95) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Zeng, YM | 1 |
| Lu, YQ | 1 |
| Qin, YY | 1 |
| Chen, YK | 1 |
| Wei, HX | 1 |
| Wei, SS | 1 |
| Lindsay, DS | 1 |
| Peng, HJ | 1 |
| Pfeffer, G | 1 |
| Prout, A | 1 |
| Hooge, J | 1 |
| Maguire, J | 1 |
| Faucher, B | 1 |
| Moreau, J | 1 |
| Zaegel, O | 1 |
| Franck, J | 1 |
| Piarroux, R | 1 |
| Hill, D | 1 |
| Dubey, JP | 1 |
| Happe, S | 1 |
| Fischer, A | 1 |
| Heese, Ch | 1 |
| Reichelt, D | 1 |
| Grüneberg, U | 1 |
| Freund, M | 1 |
| Kloska, S | 1 |
| Evers, S | 1 |
| Husstedt, IW | 1 |
| Soto-Hernández, JL | 1 |
| Moreno-Andrade, T | 1 |
| Góngora-Rivera, F | 1 |
| Ramírez-Crescencio, MA | 1 |
| Gottlieb, MS | 2 |
| Knight, S | 1 |
| Mitsuyasu, R | 1 |
| Weisman, J | 1 |
| Roth, M | 1 |
| Young, LS | 2 |
| Langmann, P | 1 |
| Klinker, H | 1 |
| Richter, E | 1 |
| Potter, JL | 1 |
| Kofron, WG | 1 |
| Jurado, R | 1 |
| Garcia-Herola, A | 1 |
| Garcia-Lazaro, M | 1 |
| Kindelan, JM | 1 |
| Villanueva, JL | 1 |
| Torre-Cisneros, J | 1 |
| Brossard, G | 1 |
| Neau, D | 1 |
| Barbeau, P | 1 |
| Pellegrin, JL | 2 |
| Leng, B | 1 |
| Glatt, AE | 1 |
| Schlienger, RG | 1 |
| Haefeli, WE | 1 |
| Bircher, A | 1 |
| Leib, SL | 1 |
| Lüscher, TF | 1 |
| Ragnaud, JM | 1 |
| Morlat, P | 4 |
| Dupon, M | 1 |
| Lacoste, D | 1 |
| Chene, G | 1 |
| Murray-Pulsifer, K | 1 |
| Winstanley, P | 1 |
| Khoo, S | 1 |
| Szwandt, S | 1 |
| Edwards, G | 2 |
| Wilkins, E | 1 |
| Tija, J | 1 |
| Coker, R | 1 |
| McKane, W | 1 |
| Beeching, N | 1 |
| Watkin, S | 1 |
| Halme, M | 1 |
| Jokipii, L | 1 |
| Jokipii, AM | 1 |
| Ristola, M | 1 |
| Lähdevirta, J | 1 |
| Antinori, A | 2 |
| Murri, R | 1 |
| Ammassari, A | 2 |
| De Luca, A | 1 |
| Linzalone, A | 1 |
| Cingolani, A | 1 |
| Damiano, F | 2 |
| Maiuro, G | 2 |
| Vecchiet, J | 1 |
| Scoppettuolo, G | 1 |
| Ferrer, S | 1 |
| Fuentes, I | 1 |
| Domingo, P | 1 |
| Muñoz, C | 1 |
| Iranzo, A | 1 |
| Barrio, JL | 1 |
| Fuster, M | 1 |
| Ris, J | 1 |
| Sambeat, MA | 1 |
| Cadafalch, J | 1 |
| Nolla, J | 1 |
| Wei, ME | 1 |
| Campbell, SH | 1 |
| Taylor, C | 1 |
| Moreno García, M | 1 |
| Fernández González, F | 1 |
| Fernández Rodríguez, E | 1 |
| Portús de Marco, MV | 1 |
| Katlama, C | 4 |
| Mouthon, B | 1 |
| Gourdon, D | 1 |
| Lapierre, D | 1 |
| Rousseau, F | 1 |
| Laing, RB | 1 |
| Flegg, PJ | 1 |
| Brettle, RP | 1 |
| Leen, CL | 1 |
| Burns, SM | 1 |
| Giacometti, A | 1 |
| Cirioni, O | 1 |
| Scalise, G | 1 |
| Ebrahimzadeh, A | 1 |
| Bottone, EJ | 1 |
| de Luis, DA | 1 |
| Fortun, J | 1 |
| Pintado, V | 1 |
| Aller de la Fuente, R | 1 |
| Schmidt-Westhausen, A | 1 |
| Grünewald, T | 1 |
| Reichart, PA | 1 |
| Pohle, HD | 2 |
| Derouin, F | 3 |
| Gérard, L | 1 |
| Farinotti, R | 1 |
| Maslo, C | 1 |
| Leport, C | 12 |
| Payen, MC | 1 |
| De Wit, S | 1 |
| Sommereijns, B | 1 |
| Clumeck, N | 2 |
| García Vázquez, E | 1 |
| de Górgolas Hernández, M | 1 |
| García Delgado, R | 1 |
| Fernández Guerrero, ML | 1 |
| Almond, DS | 1 |
| Szwandt, IS | 1 |
| Lee, MG | 1 |
| Winstanley, PA | 1 |
| Chirgwin, K | 1 |
| Hafner, R | 4 |
| Remington, J | 1 |
| Andersen, J | 1 |
| Bosler, EM | 1 |
| Roque, C | 1 |
| Rajicic, N | 1 |
| McAuliffe, V | 1 |
| Jayaweera, DT | 1 |
| Vilde, JL | 10 |
| Luft, BJ | 4 |
| Jacobson, MA | 2 |
| Besch, CL | 2 |
| Child, C | 2 |
| Matts, JP | 1 |
| Muth, K | 2 |
| Wentworth, DN | 1 |
| Deyton, L | 2 |
| Meulemans, A | 1 |
| Robine, D | 1 |
| Dameron, G | 1 |
| Camilli, G | 1 |
| Federico, G | 1 |
| Pizzigallo, E | 1 |
| Tamburrini, E | 1 |
| Araujo, FG | 1 |
| Prokocimer, P | 1 |
| Lin, T | 1 |
| Remington, JS | 5 |
| Iannucci, AA | 1 |
| Hart, LL | 1 |
| Hardy, WD | 2 |
| Mallolas, J | 3 |
| Zamora, L | 1 |
| Gatell, JM | 3 |
| Miró, JM | 3 |
| Soriano, E | 1 |
| Dannemann, B | 1 |
| McCutchan, JA | 2 |
| Israelski, D | 1 |
| Antoniskis, D | 2 |
| Luft, B | 1 |
| Nussbaum, J | 1 |
| Chiu, J | 2 |
| de Gans, J | 1 |
| Portegies, P | 1 |
| Reiss, P | 1 |
| Troost, D | 1 |
| van Gool, T | 1 |
| Lange, JM | 1 |
| Poizot-Martin, I | 1 |
| Lafeuillade, A | 1 |
| Dhiver, C | 1 |
| Xeri, L | 1 |
| Bouabdallah, R | 1 |
| Gamby, T | 1 |
| Gastaut, JA | 1 |
| Niyongabo, T | 2 |
| Fernandez-Martin, J | 2 |
| Meyohas, MC | 2 |
| Chauvin, JP | 1 |
| Vinogradov, NA | 1 |
| Clotet, B | 1 |
| Sirera, G | 1 |
| Romeu, J | 1 |
| Gimeno, JM | 1 |
| Jou, A | 1 |
| Condom, MJ | 1 |
| Tor, J | 1 |
| Foz, M | 1 |
| Heald, A | 1 |
| Flepp, M | 1 |
| Chave, JP | 1 |
| Malinverni, R | 1 |
| Rüttimann, S | 1 |
| Gabriel, V | 1 |
| Renold, C | 1 |
| Sugar, A | 1 |
| Hirschel, B | 1 |
| Díaz Benito, JA | 1 |
| Rodríguez García, JC | 1 |
| Piñeiro Gómez-Durán, L | 1 |
| Rolston, KV | 3 |
| Ruf, B | 1 |
| Foppa, CU | 1 |
| Bini, T | 1 |
| Gregis, G | 1 |
| Lazzarin, A | 1 |
| Esposito, R | 1 |
| Moroni, M | 1 |
| Tournerie, C | 1 |
| Raguin, G | 1 |
| Dannemann, BR | 2 |
| Israelski, DM | 1 |
| Nussbaum, JN | 1 |
| Orellana, M | 1 |
| Holliman, RE | 2 |
| González-Clemente, JM | 2 |
| Pedrol, E | 2 |
| Alvarez, R | 2 |
| Graus, F | 2 |
| Mercader, JM | 2 |
| Guelar, A | 1 |
| Jiménez de Anta, MT | 2 |
| Lucey, DR | 1 |
| Lucey, CR | 1 |
| Simon, DI | 1 |
| Brosius, FC | 1 |
| Rothstein, DM | 1 |
| Knani, L | 1 |
| Bouslama, K | 1 |
| Varette, C | 1 |
| Gonzalez Canali, G | 1 |
| Cabane, J | 1 |
| Lebas, J | 1 |
| Imbert, JC | 1 |
| Chakroun, M | 1 |
| Pelosse, B | 1 |
| Zazoun, L | 1 |
| Vacherot, B | 1 |
| Boudes, P | 1 |
| Zittoun, J | 1 |
| Sobel, A | 1 |
| Mitchell, CD | 1 |
| Erlich, SS | 1 |
| Mastrucci, MT | 1 |
| Hutto, SC | 1 |
| Parks, WP | 1 |
| Scott, GB | 1 |
| Grange, F | 1 |
| Kinney, EL | 1 |
| Monsuez, JJ | 1 |
| Rybojad, M | 1 |
| Khuong, MA | 1 |
| Janier, M | 1 |
| Bhatti, N | 1 |
| Larson, E | 1 |
| Berenguer, J | 1 |
| Kassirer, JP | 1 |
| Kopelman, RI | 1 |
| Caumes, E | 1 |
| Feyeux, C | 1 |
| Garrouste, MT | 1 |
| Schlemmer, B | 1 |
| Wallach, D | 1 |
| Carrazana, EJ | 1 |
| Rossitch, E | 1 |
| Samuels, MA | 1 |
| Lidman, C | 1 |
| Ortqvist, A | 1 |
| Lundbergh, P | 1 |
| Julander, I | 1 |
| Bergdahl, S | 1 |
| Altés, J | 1 |
| Salas, A | 1 |
| Ricart, C | 1 |
| Villalonga, C | 1 |
| Riera, M | 1 |
| Casquero, P | 1 |
| Gilman, TM | 1 |
| Boylen, CT | 1 |
| Sattler, FR | 1 |
| Tuazon, CU | 2 |
| Cohn, JA | 1 |
| McMeeking, A | 1 |
| Cohen, W | 1 |
| Jacobs, J | 1 |
| Holzman, RS | 1 |
| Ventura, MG | 1 |
| Wybran, J | 1 |
| Farber, CM | 1 |
| Bastuji-Garin, S | 1 |
| Perronne, C | 1 |
| Salmon, D | 1 |
| Marche, C | 2 |
| Briçaire, F | 1 |
| Ingram, RJ | 1 |
| Davis, R | 1 |
| Ellis-Pegler, RB | 1 |
| Navin, TR | 1 |
| Miller, KD | 1 |
| Satriale, RF | 1 |
| Lobel, HO | 1 |
| Pape, JW | 1 |
| Verdier, RI | 1 |
| Johnson, WD | 1 |
| Kovacs, JA | 1 |
| Masur, H | 1 |
| Bonaventura, I | 1 |
| Romero, F | 1 |
| Ortega, A | 1 |
| Navarro, C | 1 |
| Juste, C | 1 |
| Codina Puiggrós, A | 1 |
| Frissen, PH | 1 |
| Stronkhorst, A | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| Danner, SA | 1 |
| Raviglione, MC | 1 |
| Dinan, WA | 1 |
| Pablos-Mendez, A | 1 |
| Palagiano, A | 1 |
| Sabatini, MT | 1 |
| Raffi, F | 1 |
| Matheron, S | 2 |
| Regnier, B | 2 |
| Saimot, AG | 2 |
| Vedrenne, C | 1 |
| Weiss, LM | 1 |
| Harris, C | 1 |
| Berger, M | 1 |
| Tanowitz, HB | 1 |
| Wittner, M | 1 |
| Fischl, MA | 1 |
| Dickinson, GM | 1 |
| Wanke, C | 1 |
| Kovacs, A | 1 |
| Dina, T | 1 |
| Davis, DO | 1 |
| Barton, N | 1 |
| Katz, D | 1 |
| Lunde, M | 1 |
| Levy, C | 1 |
| Conley, FK | 1 |
| Bath, PM | 1 |
| Lillicrap, DA | 1 |
| Winter, M | 1 |
| Pearson, RD | 1 |
| Hewlett, EL | 1 |
| Haverkos, HW | 1 |
| Hoy, J | 1 |
| Reinert, P | 1 |
| Bernaudin, F | 1 |
| Catterall, JR | 1 |
| Potasman, I | 1 |
| Navia, BA | 1 |
| Petito, CK | 1 |
| Gold, JW | 1 |
| Cho, ES | 1 |
| Jordan, BD | 1 |
| Price, RW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis[NCT00000794] | Phase 2 | 100 participants | Interventional | Completed | |||
| A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection[NCT00000666] | 600 participants | Interventional | Completed | ||||
| Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children With Sickle Cell Anaemia in Eastern and Southern Africa: a Double Blind Randomised Trial (CHEMCHA)[NCT04844099] | Phase 3 | 723 participants (Actual) | Interventional | 2021-04-09 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for pyrimethamine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Antiprotozoal Agents; Azithromycin; Clind | 2015 |
Toxoplasma gondii: transmission, diagnosis and prevention.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Protozoan; Cats; Cattle; Deer; Encephalitis | 2002 |
Clindamycin in the treatment of toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Humans; Pyrimethamine; Retrospective Studies; Sulfa | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
[Cutaneo-mucosal hyperpigmentation in AIDS. 4 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Ketoconazole; Male; Middle Aged; Nail Diseases; P | 1991 |
[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Folic Acid; Hematologic Diseases; Hum | 1991 |
[Diagnosis and treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Diagnosis, Differential; Humans; Pneumonia, Pneumoc | 1991 |
Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Crystallization; Drug Therapy, Combi | 1990 |
Prophylaxis of AIDS-related opportunistic infections (OIs).
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combin | 1989 |
Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Therapy, Combination; Humans; Pneumonia, Pneumocys | 1989 |
Toxoplasmosis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Therapy, Combination; Humans; Mice; Opportunistic | 1989 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, | 1988 |
Prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneum | 1988 |
AIDS commentary. Toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Bacterial Agents; Antibodies, Protozoan; Antimetab | 1988 |
Toxoplasmosis and the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Africa; Animals; Antibodies, Protozoan; Drug Combinations; Human | 1988 |
Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Topics: Acquired Immunodeficiency Syndrome; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria | 1987 |
17 trials available for pyrimethamine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-I | 2020 |
[Primary prophylaxis against cerebral toxoplasmosis. Efficacy of folinic acid in the prevention of hematologic toxicity of pyrimethamine].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Blood Cell Count; | 1994 |
Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Female; Humans; Male; Middle Aged; | 1995 |
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infe | 1995 |
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Atovaquone; Clindamycin; Encephalit | 1996 |
A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infecti | 1997 |
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Ani | 2002 |
Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Clindamycin; Double-Blind Method; Encephalitis; | 1992 |
Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Diseases; Clindamycin; Drug Combinations; | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Follow-Up Studies; Humans; Pentamidine; Pneumonia, Pneu | 1991 |
Clinical programs for clinical research on AIDS: description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Clindamycin; Encephalitis; Humans; L | 1991 |
Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clindamycin; Drug Evaluation; Drug Therapy, Combination; | 1992 |
Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Drug Therapy, Combination; Encephalitis; Humans; Op | 1991 |
Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Drug Therapy, Combination; Encephalitis; Humans; In | 1991 |
Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Chronic Disease; Coccidiosis; Drug Administration Schedule; Drug | 1989 |
Pneumocystis carinii pneumonia in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Bronchoscopy; Clinical Trials as Topic; Dapsone; Drug C | 1985 |
73 other studies available for pyrimethamine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antiretroviral Therapy, Highly Active; Biopsy; C | 2009 |
Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiprotozoal Agents; CD4 Lymphocyte Cou | 2011 |
[HIV-associated cerebral toxoplasmosis -- review and retrospective analysis of 36 patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Antiretrovir | 2002 |
Nocardia abscess during treatment of brain toxoplasmosis in a patient with aids, utility of proton MR spectroscopy and diffusion-weighted imaging in diagnosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Retroviral Agents; Anticonvul | 2006 |
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamin | 1984 |
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Resistance; Drug Therapy, Combination; Humans; Pyr | 1995 |
Sulfadiazine/N4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Hemophilia A; Huma | 1994 |
Pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Female; Humans; Male; Middle Aged; Pne | 1994 |
Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clindamycin; Dapso | 1994 |
[Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Humans; Male; Middle Aged; Phenytoin; Pyrimethamine; Stevens-Joh | 1993 |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Cl | 1993 |
Two central nervous system infectious diseases in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Hu | 1993 |
Toxoplasma pneumonia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Bact | 1995 |
[Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clind | 1996 |
Precipitous visual loss secondary to optic nerve toxoplasmosis as an unusual presentation of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therap | 1996 |
[Granulocyte colony-stimulating factor in the treatment of neutropenia associated with HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Anti-Infective Agents; Antiviral Agents; Cefta | 1996 |
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal | 1996 |
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Artemisin | 1996 |
Persistent diarrhea caused by Isospora belli: therapeutic response to pyrimethamine and sulfadiazine.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Infective Agents; Antitrichomonal Agents; Diarrhea | 1996 |
[HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory | 1997 |
Oral manifestations of toxic epidermal necrolysis (TEN) in patients with AIDS: report of five cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Age | 1998 |
Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dr | 1998 |
[Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; A | 1999 |
Disposition of intravenous pyrimethamine in healthy volunteers.
Topics: Acquired Immunodeficiency Syndrome; Antimalarials; Encephalitis; Humans; Infusions, Intravenous; Mal | 2000 |
Levels of pyrimethamine in serum and penetration into brain tissue in humans.
Topics: Acquired Immunodeficiency Syndrome; Brain; Dose-Response Relationship, Drug; Humans; Pyrimethamine; | 1992 |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Animals; Brain Diseases; Chronic Disease; Clarith | 1992 |
Clindamycin for toxoplasma encephalitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Drug Combinations; Encephalitis; Humans; Pyrimetham | 1991 |
Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Therapy, Combination; Female; Humans; Male; Opportun | 1992 |
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Brain; Clarithromycin; Drug Therapy, Combination; Erythromycin; | 1991 |
Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Dapsone; Drug Administration Schedule; Drug Ther | 1991 |
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Clindamycin; Cohort Studies; Drug Therapy, Combinat | 1991 |
[Cerebral toxoplasmosis as a cause of treatable dementia in an aged patient].
Topics: Acquired Immunodeficiency Syndrome; Aged; Brain; Brain Diseases; Dementia; Humans; Male; Pyrimethami | 1991 |
Treatment of acute toxoplasmosis with oral clindamycin.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Administration, Oral; Adult; Clindamycin; Drug Th | 1991 |
Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Brain Diseases; Clindamycin; Drug Therapy, Combin | 1991 |
A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Clindamycin; Drug Therapy, Combinat | 1991 |
Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Drug Therapy, Combination; Encephalitis; Follow-Up | 1991 |
Clinical and diagnostic findings in 20 patients with toxoplasmosis and the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Drug Therapy, Combination; England; Enzyme-Linke | 1991 |
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Biopsy; Brain; Brain Diseases; Clindamycin; Drug | 1990 |
Infectious disease emergencies in persons with HIV/AIDS: an update.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Clindamycin; Communicable Diseases; Fluconazole; | 1990 |
[Pulmonary toxoplasmosis in AIDS. Report of 3 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; | 1990 |
[Ocular toxoplasmosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Humans; Male; Middle Aged; Opportunistic | 1990 |
[Acute pancytopenia induced by pyrimethamine during treatment of cerebral toxoplasmosis associated with AIDS. Role of dihydrofolate reductase inhibitors].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Brain Diseases; Folic Acid Antagonists; Fo | 1990 |
Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
Topics: Acquired Immunodeficiency Syndrome; Animals; Central Nervous System Diseases; Family Health; Female; | 1990 |
Successful therapy for Toxoplasma gondii myocarditis in acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Aged; Clindamycin; Humans; Male; Myocarditis; Pyrimethamine; Tox | 1990 |
Low-dose alternate-day pyrimethamine for maintenance therapy in cerebral toxoplasmosis complicating AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Brain Diseases; Drug Administratio | 1990 |
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Diseases; Clindamycin; Drug Combinations; | 1990 |
Toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Encephalitis; Humans; Opportunistic Infection | 1990 |
Toxoplasmic encephalitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antibodies, Protozoan; Brain; Diagnosis, Differe | 1989 |
Interpreting negative test results.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Diagnosis, Differential; False Negative R | 1989 |
[Bullous toxic skin disease with fatal outcome in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Humans; Male; Middle Aged; Prognosis; Pyrimethamine; Stevens-Joh | 1989 |
Cerebral toxoplasmosis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Encephalitis; Female; Humans; Male; Middle Aged; Py | 1989 |
Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Dapsone; Drug Evaluation; Drug Therapy, Combination | 1989 |
[Cerebral toxoplasmosis in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Drug Evaluation; Drug Therapy, Combinatio | 1989 |
Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Brain; Clindamycin; Encephalitis; Female; Humans; | 1989 |
Sulfadiazine revisited.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Brain Diseases; Crystallization; D | 1989 |
An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Clindamycin; Drug Therapy, Combination; Humans; | 1989 |
Experience with pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Bronchoscopy; Drug Combinations; Follow-Up Studies; Homos | 1989 |
Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; | 1985 |
Adverse reactions to pyrimethamine-sulfadoxine in context of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Drug Hypersensitivity; Humans; Pyrimethamine; | 1985 |
[Cerebral toxoplasmosis in the acquired immunodeficiency syndrome. Study of the clinical, radiological, and pathological findings in 10 cases].
Topics: Acquired Immunodeficiency Syndrome; Brain Abscess; Brain Diseases; Humans; Opportunistic Infections; | 1988 |
Fansidar and Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; | 1988 |
Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Male; Middle Aged; Pneumonia, Pneumoc | 1988 |
Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Central Nervous System Diseases; Drug Therapy, Combinatio | 1988 |
Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Encephalitis; Humans; Pyrimethamine; Toxoplasmosi | 1988 |
Clindamycin in cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Clindamycin; Drug Therapy, Combination; Humans; | 1988 |
Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamin | 1986 |
Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibodies; Drug Therapy, Combination; Encephalitis; Huma | 1987 |
Fansidar--a treatment for AIDS-related pneumocystis?
Topics: Acquired Immunodeficiency Syndrome; Antimalarials; Drug Combinations; Humans; Pneumonia, Pneumocysti | 1987 |
Assessment of therapy for toxoplasma encephalitis. The TE Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Adult; Encephalitis; Evaluation Studies | 1987 |
[Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment].
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Drug Combinations; Female; Humans; Leucom | 1987 |
Role of clindamycin in the treatment of central nervous system toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Central Nervous System Diseases; Clindamycin; Drug Therap | 1987 |
[Opportunistic Toxoplasma gondii infections].
Topics: Acquired Immunodeficiency Syndrome; Child, Preschool; Drug Combinations; Humans; Immunologic Deficie | 1985 |
Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Brain Diseases; Central Nervous System; Clindamyc | 1986 |